Market Maker Surveillance Report. NUS, CYTK, HLF, ARSD, MGT, ROSG, Winning Stocks With Lowest Price Friction For Wednesday, Ma
May 16, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3836 companies with "abnormal" market making, 1806 companies with positive Friction Factors and 4019 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. NU Skin Enterprises Inc (NYSE:NUS), CYTOKINETICS INC (NASDAQ:CYTK), HERBALIFE LTD (NYSE:HLF), ARABIAN AMERICAN DEVELOPMENT (NASDAQ:ARSD), MGT CAPITAL INVESTMENTS INC (AMEX:MGT), ROSETTA GENOMICS LTD (NASDAQ:ROSG). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction NUS $5.790 14.40% 2,153,706 27.70% 2,125,555 27.34% 28,151 49 CYTK $0.160 17.78% 60,438 59.58% 41,001 40.42% 19,437 1,215 HLF $8.560 20.17% 5,536,780 30.18% 5,197,664 28.33% 339,116 396 ARSD $1.070 12.90% 52,328 31.50% 43,431 26.14% 8,897 83 MGT $0.880 20.41% 54,307 44.20% 37,858 30.81% 16,449 187 ROSG $3.250 200.62% 3,087,107 51.06% 2,818,629 46.62% 268,478 826Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows NUS with a dollar gain Wednesday of $5.79000 and a Friction Factor of 49 shares. That means that it only took 49 more shares of buying than selling to move NUS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
NU Skin Enterprises Inc (NYSE:NUS) - Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements worldwide. The company sells its personal care products under the Nu Skin brand; and nutritional supplements under the Pharmanex brand. Its personal care product line includes core systems, targeted treatments, total care, cosmetic, and Epoch, a product formulated with botanical ingredients. The companys nutritional supplements product line comprises micronutrient supplements, targeted solution supplements, and weight management products. It also sells Vitameal, which are nutritious meal products for starving children or purchased for personal food storage. In addition, the company offers other products and services consisting of digital content storage, water purifiers, and other household products. It sells its products primarily through a network of independent distributors in north Asia, the Americas, Greater China, Europe, and the south Asia/Pacific. The company also operates retail stores to sell its products in China. As of December 31, 2010, Nu Skin Enterprises operated 40 stores throughout China. The company was founded in 1984 and is headquartered in Provo, Utah.
CYTOKINETICS INC (NASDAQ:CYTK) - Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. It primarily offers omecamtiv mecarbil, a cardiac muscle myosin activator, which is in Phase I/IIa clinical trials for the treatment of heart failure; CK-2017357, which is a Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis; and CK-2066260, a fast skeletal muscle sarcomere activator for the treatment of diseases and conditions associated with muscle weakness or wasting. The companys cancer treatment products under development stage comprise ispinesib, SB-743921, and GSK-923295. It has a strategic alliance with Amgen Inc. to discover, develop, and commercialize novel small molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure. The company was founded in 1997 and is headquartered in South San Francisco, California.
HERBALIFE LTD (NYSE:HLF) - Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. It offers science based products in four principal categories: weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. The companys weight management product portfolio includes meal replacement shakes, weight-loss enhancers, appetite suppressors, and a range of healthy snacks. Its targeted nutrition products comprise dietary supplements, which contain herbs, vitamins, minerals, and natural ingredients that support good health. The companys energy, sports, and fitness products consist of energy and isotonic drinks to support a healthy active lifestyle. Its outer nutrition products include skin cleansers, toners, moisturizers and facial masks, shampoos and conditioners, anti-aging products, body-wash items, and a selection of fragrances for men and women. The company also sells literature and promotional materials, including sales aids, informational audiotapes, videotapes, CDs, and DVDs designed to support its distributors marketing efforts, as well as start-up kits for new distributors. It sells its products through a network of independent distributors, as well as through its retail stores and sales force in China. The company was founded in 1980 and is based in Grand Cayman, Cayman Islands.
ARABIAN AMERICAN DEVELOPMENT (NASDAQ:ARSD) - Arabian American Development Company, through its subsidiaries, engages in the manufacture and sale of various specialty petrochemical products, as well as the development of mineral properties in Saudi Arabia and the United States. It produces high purity petrochemical solvents and other petroleum based products, including iso-pentane, normal pentane, isohexane, and hexane; and owns and operates three pipelines. The company, through its 50% interest in Al Masane Al Kobra Mining Company, holds a mining lease for the production of copper, zinc, gold, and silver and covers approximately 44 square kilometer area in the Al Masane area in southwestern Saudi Arabia. Arabian American Development Company was founded in 1967 and is based in Sugar Land, Texas.
MGT CAPITAL INVESTMENTS INC (AMEX:MGT) - MGT Capital Investments, Inc., through its subsidiaries, engages in the medical imaging business in United Kingdom, other parts of Europe, the United States, Japan, and China. It develops and commercializes computer aided detection (CAD) and image analysis software, which analyzes computer tomography (CT) scans to assist radiologists in the early detection and measurement of colorectal polyps and lung lesions. The companys products include ColonCAD software, which displays CAD marks on the images focusing on potential polyps; MedicRead product, a visualisation software application for CT colonography; and MedicCO2LON, which is an automated carbon dioxide insufflation device. It also provides a Web portal containing an online sales channel for diagnostic, treatment, and surgery planning solutions. The company was formerly known as Medicsight Inc. and changed its name to MGT Capital Investments, Inc. in January 2007. MGT Capital Investments, Inc. was founded in 1999 and is based in London, the United Kingdom.
ROSETTA GENOMICS LTD (NASDAQ:ROSG) - Rosetta Genomics Ltd. develops microRNA-based diagnostic and in Israel. MicroRNAs are naturally expressed, or produced, using instructions encoded in deoxyribonucleic acid and are used in regulating protein production. The company develops microRNA-based diagnostic programs for various cancers, as well as for the identification of the origin of the primary tumor of metastases; for differentiating squamous from non squamous non-small cell lung cancer; and for differentiating mesothelioma from other carcinomas in the lung and pleura. The company also focuses on the development of body fluid-based diagnostic tests. In addition, it develops microRNA-based therapeutic products for the treatment of liver cancer. The company has a license and collaboration agreement with Prometheus Laboratories Inc. to license and sublicense certain rights related to the companys microRNA-based cancer diagnostic tests; and a collaboration agreement with CBR Institute for Biomedical Research to study the role of microRNAs in hematopoeisis. Rosetta Genomics Ltd. was founded in 2000 and is based in Rehovot, Israel.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net